- cafead   Jun 20, 2023 at 10:02: AM
via When Vera Therapeutics released initial mid-stage data on its immunoglobulin A nephropathy (IgAN) project atacicept in January investors were disappointed with an apparently uncompetitive reduction in proteinuria at 24 weeks. Now comes better news.
article source
article source